TIAA CREF INVESTMENT MANAGEMENT LLC - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 89 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$1,354,000
+0.9%
112,204
+5.0%
0.00%0.0%
Q4 2018$1,342,000
-66.7%
106,904
-60.6%
0.00%0.0%
Q3 2018$4,024,000
+35.0%
271,198
+53.1%
0.00%
-50.0%
Q2 2018$2,981,000
-7.9%
177,099
+25.3%
0.00%0.0%
Q1 2018$3,236,000
-27.9%
141,312
-18.5%
0.00%
-33.3%
Q4 2017$4,487,000
+173.8%
173,457
+56.1%
0.00%
+200.0%
Q3 2017$1,639,000
-9.5%
111,114
-14.4%
0.00%0.0%
Q2 2017$1,811,000
-15.2%
129,819
+3.7%
0.00%
-50.0%
Q1 2017$2,136,000
+95.6%
125,183
+18.0%
0.00%
+100.0%
Q4 2016$1,092,000
+3.3%
106,105
+1.5%
0.00%0.0%
Q3 2016$1,057,000
-11.5%
104,547
-1.7%
0.00%0.0%
Q2 2016$1,195,000
-16.7%
106,406
+1.3%
0.00%0.0%
Q1 2016$1,435,000
-26.7%
105,016
+1.8%
0.00%0.0%
Q4 2015$1,957,000
+28.3%
103,170
+26.9%
0.00%0.0%
Q3 2015$1,525,000
+535.4%
81,270
+405.0%
0.00%
Q2 2015$240,000
+500.0%
16,093
+403.5%
0.00%
Q3 2014$40,000
-88.2%
3,196
-90.5%
0.00%
Q2 2014$340,000
-0.3%
33,696
+32.8%
0.00%
Q1 2014$341,00025,3640.00%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
BVF INC/IL 3,135,289$46,246,0005.88%
GREAT POINT PARTNERS LLC 2,006,211$29,592,0005.76%
Lyon Street Capital, LLC 463,064$6,830,0002.63%
SENZAR ASSET MANAGEMENT, LLC 335,445$4,948,0001.21%
INGALLS & SNYDER LLC 1,209,062$17,834,0000.93%
Senvest Management, LLC 314,629$4,641,0000.31%
KNOTT DAVID M 45,000$664,0000.28%
DRIEHAUS CAPITAL MANAGEMENT LLC 262,569$3,873,0000.15%
PRINCETON CAPITAL MANAGEMENT INC 14,607$215,0000.11%
Manchester Capital Management LLC 19,984$295,0000.05%
View complete list of CONCERT PHARMACEUTICALS INC shareholders